Drug shows promise in taming painful arthritis in Real-World patients

NCT ID NCT04517669

Summary

This study observed how well the existing drug tofacitinib worked for people with psoriatic arthritis in their normal, everyday treatment. It followed 116 patients for a year to see if the drug could reduce their disease activity, help them achieve remission, and improve their quality of life. The goal was to understand the drug's real-world effectiveness, not to test a new cure.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PSORIATIC ARTHRITIS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Locations

  • AZ Sint-Jan

    Bruges, 8000, Belgium

  • Algemeen Stedelijk Ziekenhuis

    Aalst, 9300, Belgium

  • Barzilai Medical Center

    Ashkelon, Israel

  • Bnai Zion Medical Center

    Haifa, 31048, Israel

  • C.H. Universitario de Vigo- Hospital Meixoeiro

    Vigo, Galicia, 36200, Spain

  • CHR Orleans

    Orléans, 45067, France

  • CHU Besançon - Hôpital Jean Minjoz

    Besançon, 25000, France

  • CHU Clermont Ferrand - Hopital Gabriel Montpied

    Clermont-Ferrand, 63000, France

  • CHU Tours - Hôpital Trousseau

    Tours, 37044, France

  • Centre Hospitalier Jean Rougier

    Cahors, 46000, France

  • Chaim Sheba Medical Center

    Ramat Gan, 52621, Israel

  • Galilee Medical Center

    Nahariya, Israel

  • Hadassah Hebrew University Medical Center - Ein Kerem

    Jerusalem, 91120, Israel

  • Hadassah University Hospital - Ein Kerem

    Jerusalem, 246000, Israel

  • Hopital Pasteur

    Nice, 6001, France

  • Hopital Purpan

    Toulouse, 31059, France

  • Hospital Quironsalud Infanta Luisa

    Seville, 41010, Spain

  • Hospital Regional Universitario de Malaga

    Málaga, 29010, Spain

  • Hospital Universitario Central de Asturias

    Oviedo, 33011, Spain

  • Hospital Universitario Puerta del Mar

    Cadiz, 11009, Spain

  • Hospital Universitario Reina Sofia

    Córdoba, 14004, Spain

  • Hospital Universitario San Cecilio

    Granada, 18012, Spain

  • Hospital Universitario Virgen Macarena

    Seville, 41009, Spain

  • Hospital Universitario Virgen de las Nieves

    Granada, 18014, Spain

  • Hospital de Especialidades de Jerez de la Frontera

    Cadiz, 11407, Spain

  • Infirmerie Protestante de Lyon

    Caluire-et-Cuire, 69300, France

  • Karolinska University Hospital, Solna

    Stockholm, Sweden

  • Lund University

    Lund, Sweden

  • Medisch Centrum Leeuwarden

    Leeuwarden, Netherlands

  • Medisch Spectrum Twente, Haaksbergerstraat

    Enschede, 7512 KZ, Netherlands

  • Norrlands University Hospital Umeå, Reumatologiska kliniken Västerbotten

    Umeå, Sweden

  • Nova Reuma Społka Partnerska

    Genk, 3600, Belgium

  • Rambam Health Care Center

    Haifa, Israel

  • Sheba Medical Center

    Ramat Gan, Israel

  • Skånes Universitetssjukhus, Malmö

    Malmo, Sweden

  • Soroka University Medical Center

    Beersheba, 84001, Israel

  • Sygehus Vendsyssel Hospital

    Hjørring, Denmark

  • Tel Aviv Sourasky Medical Center

    Tel Aviv, Israel

  • The Baruch Padeh Medical Center - Poriya

    Tiberias, 15208, Israel

  • The Lady Davis Carmel Medical Center

    Haifa, 3436212, Israel

  • Turku University Hospital

    Turku, Finland

Conditions

Explore the condition pages connected to this study.